Table 4.
EVs source | EVs type | EVs isolation | Experimental model (target cells/animal models) | Functional cargo | Molecules/pathways activated | Key functions/downstream genes | Reference |
---|---|---|---|---|---|---|---|
BM-MSCs | Unclear |
0.22-μm pore membrane filtration PEG ultrafiltration Centrifugation |
In vivo (male C57BL6 mice/MCAO model) | / | / | Formation of new endothelial cells | Doeppner et al. [12] |
BM-MSCs | Exosomes |
0.2-μm pore membrane filtration Differential centrifugation Ultracentrifugation |
In vivo (male Wistar rats/MCAO model) | / | / | Promote angiogenesis after stroke | Xin et al. [118] |
ADSCs | Exosomes | Total exosome isolation kit |
In vitro (BMECs) In vivo (male Wistar rats/MCAO model) |
miR-181b-5p | TRPM7 axis | TRPM7↓→HIF-1α and VEGF↑ TIMP3↓ | Yang et al. [119] |
Abbreviation: BM-MSCs bone marrow-mesenchymal stem cells, ADSCs adipose-derived stem cells, MCAO middle cerebral artery occlusion model, TRPM7 transient receptor potential melastatin 7, HIF-1a hypoxia-inducible factor 1 alpha, VEGF vascular endothelial growth factor